Chinese English Germany Japanese

TargetMol Chemicals Inc.회사는 제품 목록을 제공합니다.

회사 명:TargetMol Chemicals Inc.
전화:781-+1-781-999-5354
이메일:marketing@targetmol.com
국적:United States
URL: https://www.targetmol.com/
총 제품 수:19892
31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135

제품 카탈로그

OMDM-1；(Z)-N-[(2S)-1-hydroxy-3-(4-hydroxyphenyl)propan-2-yl]octadec-9-enamide616884-62-9C27H45NO3
OMDM-2616884-63-0C27H45NO3
OMDM-6616884-67-4C28H42N2O3
OMDM-3616884-64-1C29H43NO3
OMDM-4616884-65-2C29H43NO3
OMDM-5616884-66-3C26H44N2O3
Ophiobolin B5601-74-1C25H38O4
Opioid receptor modulator 177514-44-4C18H23NO2
OP-10741443752-76-8C29H31NO4
Omeprazole-d3；H 16868 D3;Omeprazole D3922731-01-9C17H16D3N3O3S
Pilocarpine nitrate；Pilofrin;Pilagan148-72-1C11H17N3O5
ON 1460401404231-34-0C24H23N7O3S
Omeprazole metabolite Omeprazole sulfone；Omeprazole sulphone;Omeprazole sulfone88546-55-8C17H19N3O4S
Tirabrutinib hydrochloride；GS-4059 (hydrochloride);ONO-4059 (hydrochloride)1439901-97-9C25H23ClN6O3
ORM-10103488847-28-5C20H16N2O4
Orelabrutinib；ICP-0221655504-04-3C26H25N3O3
Oral antiplatelet agent 12299200-91-0C23H24N4O5S
OR-1896220246-81-1C13H15N3O2
Org3095899957-90-1C21H30O2S2
OSMI-32260791-13-5C32H35N3O9S2
ORM-153411297537-33-7C19H17ClN6O2
Mepyramine maleate；Pyrilamine maleate2-(4-메톡시벤질-N-(2-피리딜)아미노)에틸다이메틸아민말리에이트59-33-6C21H27N3O5
ORM-10962763926-98-3C27H29N3O4
OSMI-42260791-14-6C27H26ClN3O7S2
Ornidazole (Levo-)；(S)-Ornidazole;Levornidazole166734-83-4C7H10ClN3O3
ORL1 antagonist 11174985-59-1C20H22ClN5
Orotic acid-6-C1413186-54-4C5H4N2O4
Oxolinic acid；Dioxacin;Urinox;Emyrenil;Nidantin;NSC 110364옥솔린산14698-29-4C13H11NO5
Org-1049083507-02-2C17H19NO
OSMI-22260542-60-5C26H25N3O7S2
Oxidopamine hydrochloride；6-Hydroxydopamine hydrochloride;6-OHDA hydrochloride6-히드록시도파민 염화수소산염28094-15-7C8H12ClNO3
Oxythiamine diphosphate10497-04-8C12H17N3O8P2S
Benzquinamide；BZQ;Benzoquinamide;P264763-12-7C22H32N2O5
p53 and MDM2 proteins-interaction-inhibitor (chiral)；p53-and-mdm2-proteins-interaction-inhibitor-chiral939981-37-0C40H49Cl2N5O4
Oxidopamine hydrobromide；6-Hydroxydopamine hydrobromide;6-OHDA hydrobromide6-히드록시도파민 브롬화수소산염636-00-0C8H12BrNO3
Paprotrain；(alphaZ)-alpha-(3-Pyridinylmethylene)-1H-indole-3-acetonitrile57046-73-8C16H11N3
5,5-Dimethyloxazolidine-2,4-dione；Dimethyloxazolidinedione;Dimethadion;Dimethadione다이메타다이온695-53-4C5H7NO3
OTS1869352093400-18-9C25H26ClN5O2
Oxaquin；MCB-3837;DNV3837790704-50-6C31H33F2N4O11P
CBP/p300-IN-5；P300/CBP-IN-51889284-33-6C29H27F5N6O4
Palmitoyldocosahexaenoyl phosphatidylcholine59403-54-2C46H80NO8P
para-Nitroblebbistatin1621326-32-6C18H15N3O4
OT antagonist 3925703-75-9C21H20N6O2
Palonidipine96515-73-0C29H34FN3O6
Lincomycin hydrochloride monohydrate；Lincomycin hydrochloride hydrate7179-49-9C18H37ClN2O7S
OXFBD042231747-03-6C17H16N2O3
OT-821800487-55-1C26H21FN4O
OT-R antagonist 1；Oxytocin receptor antagonist 1364071-17-0C28H29N3O4
Oxotremorine M iodide3854-04-4C11H19IN2O
Oxythiamine；Hydroxythiamin136-16-3C12H17Cl2N3O2S
p38α inhibitor 11034189-82-6C22H26F2N4O2
P-gp inhibitor 12050747-49-2C32H31N5O2
CBP/p300-IN-3；P300/CBP-IN-32299226-01-8C24H29N7O
Palbinone139954-00-0C22H30O4
Palbociclib-d8；Palbociclib D8;PD 0332991 D81628752-83-9C24H21D8N7O2
p38-α MAPK-IN-1443913-15-3C27H35N5O3
OT antagonist 1479080-38-1C22H22N4O3
P-gp modulator 12249749-39-9C41H72N2O6
OTS186935 trihydrochloride2093401-85-3C25H27Cl2N5O2
Palmitoylcarnitine팔미토일카르니틴1935-18-8C23H45NO4
p53 and MDM2 proteins-interaction-inhibitor (racemic)；p53-and-mdm2-proteins-interaction-inhibitor-racemic939983-14-9C40H49Cl2N5O4
OT-R antagonist 2；Oxytocin receptor antagonist 2364071-16-9C28H29N3O4
Pasireotide；SOM 320;SOM 230396091-73-9C58H66N10O9
PD-159020177904-00-6C32H25NO8
PD-1-IN-171673560-66-1C13H22N6O7
PDD000317052032096-45-8C20H22N6O3S3
CA-170；PD-1-IN-11673534-76-3C12H20N6O7
PAT-1251 Hydrochloride2098884-53-6C18H18ClF4N3O3
Pasireotide pamoate；SOM230 pamoate396091-79-5C58 H66 N10 O9 . C23 H16 O6
Azathioprine；BW 57-322아자티오프린446-86-6C9H7N7O2S
Pargolol hydrochloride；Ko 1400 hydrochloride36902-82-6C16H24ClNO3
PAT-5051782070-22-7C23H18ClF2N3O2S
Paxilline57186-25-1C27H33NO4
PDE2/PDE10-IN-11426833-08-0C15H10ClN5
PD-1-IN-181673534-97-8C11H17N5O8
PD-1-IN-222349372-98-9C25H25N5O4
PDE-9 inhibitor1082743-70-1C22H27N5O2
PDE1-IN-32370966-46-2C18H24N4O
PDE5-IN-22244517-61-9C25H21N3O6S
PAβN dihydrochloride；MC-207,110 dihydrochloride;Phe-Arg-β-naphthylamide dihydrochloride100929-99-5C25H32Cl2N6O2
Pasireotide L-aspartate salt；SOM230 L-aspartate396091-77-3C62H73N11O13
PD0176078248922-46-5C23H30F2N2O
PD1-PDL1-IN 12005454-12-4C14H23N7O6
PAT-12512007885-39-2C18H17F4N3O3
PD-1/PD-L1-IN 5 TFA；PD-1/PD-L1-IN 52170209-52-4C24H19F3N4O5S
PD 9078077422-99-2C19H14N4O4
Fezagepras sodium；PBI-4050 sodium salt;Setogepram sodium salt1254472-97-3C13H19NaO2
Parsaclisib；INCB0504651426698-88-5C20H22ClFN6O2
PDE12-IN-31803357-22-3C29H25N5O3
PDE1-IN-21904611-63-7C16H21BrN4O2
PDE9-IN-12305087-92-5C17H23FN6O2
Daidzein；Isoflavone다이드제인486-66-8C15H10O4
Indacaterol maleate；QAB149753498-25-8C28H32N2O7
PC9451931946-73-4C38H37F3N6O3
PARP-2-IN-12115698-83-2C21H19F4N5O3
PD 168568 dihydrochloride1782532-06-2C22H28ClN3O
PARP14 inhibitor H102084811-68-5C24H27N7O7S
PARP/PI3K-IN-12337386-47-5
Parcetasal；MR-89787549-36-8C17H15NO5
PD 123319 ditrifluoroacetate136676-91-0C33H33F3N4O5
31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135
Copyright 2019 © ChemicalBook. All rights reserved